Title Targeting ABL-IRE 1 alpha Signaling Spares ER-Stressed Pancreatic beta Cells to Reverse Autoimmune Diabetes
暂无分享,去创建一个
Dustin J Maly | J. Bluestone | R. Ghosh | F. R. Papa | B. J. Backes | Shuhei Morita | Wendy L. Rosenthal | Morvarid Mehdizadeh | Likun Wang | S. Villalta | H. C. Feldman | A. Register | I. T. Hoffmann-Petersen | Kevin Colon-Negron | RosaMeza-Acevedo | F. Papa
[1] A. Tsatsoulis,et al. Tyrosine Kinase Inhibitors and Diabetes: A Novel Treatment Paradigm? , 2015, Trends in Endocrinology & Metabolism.
[2] M. Grabherr,et al. Function of Isolated Pancreatic Islets From Patients at Onset of Type 1 Diabetes: Insulin Secretion Can Be Restored After Some Days in a Nondiabetogenic Environment In Vitro , 2015, Diabetes.
[3] F. R. Papa,et al. The role of endoplasmic reticulum stress in human pathology. , 2015, Annual review of pathology.
[4] A. Tasker,et al. Unfolded Protein Response in Cancer: IRE1α Inhibition by Selective Kinase Ligands Does Not Impair Tumor Cell Viability. , 2015, ACS medicinal chemistry letters.
[5] M. Saarma,et al. MANF is indispensable for the proliferation and survival of pancreatic β cells. , 2014, Cell reports.
[6] Jean Y. J. Wang. The Capable ABL: What Is Its Biological Function? , 2014, Molecular and Cellular Biology.
[7] G. Szot,et al. Inhibition of VEGFR-2 Reverses Type 1 Diabetes in NOD Mice by Abrogating Insulitis and Restoring Islet Function , 2013, Diabetes.
[8] K. Kemphues,et al. Nonmuscle myosin IIB links cytoskeleton to IRE1α signaling during ER stress. , 2012, Developmental cell.
[9] F. R. Papa,et al. Endoplasmic reticulum stress, pancreatic β-cell degeneration, and diabetes. , 2012, Cold Spring Harbor perspectives in medicine.
[10] P. Greengard,et al. IRE1α induces thioredoxin-interacting protein to activate the NLRP3 inflammasome and promote programmed cell death under irremediable ER stress. , 2012, Cell metabolism.
[11] R. Kaufman,et al. Endoplasmic reticulum stress and type 2 diabetes. , 2012, Annual review of biochemistry.
[12] Anna K. Schrey,et al. Dasatinib, imatinib and staurosporine capture compounds - Complementary tools for the profiling of kinases by Capture Compound Mass Spectrometry (CCMS). , 2011, Journal of proteomics.
[13] W. Kolch,et al. The secret life of kinases: functions beyond catalysis , 2011, Cell Communication and Signaling.
[14] L. Glimcher,et al. Dual and opposing roles of the unfolded protein response regulated by IRE1α and XBP1 in proinsulin processing and insulin secretion , 2011, Proceedings of the National Academy of Sciences.
[15] A. Koong,et al. Identification of an Ire1alpha endonuclease specific inhibitor with cytotoxic activity against human multiple myeloma. , 2011, Blood.
[16] James Sharpe,et al. Quantification and Three-Dimensional Imaging of the Insulitis-Induced Destruction of β-Cells in Murine Type 1 Diabetes , 2010, Diabetes.
[17] C. Hetz,et al. Fine-tuning of the unfolded protein response: Assembling the IRE1alpha interactome. , 2009, Molecular cell.
[18] N. Gray,et al. N-Myristoylated c-Abl Tyrosine Kinase Localizes to the Endoplasmic Reticulum upon Binding to an Allosteric Inhibitor* , 2009, The Journal of Biological Chemistry.
[19] F. R. Papa,et al. IRE1α Kinase Activation Modes Control Alternate Endoribonuclease Outputs to Determine Divergent Cell Fates , 2009, Cell.
[20] F. Martinon,et al. BAX inhibitor-1 is a negative regulator of the ER stress sensor IRE1alpha. , 2009, Molecular cell.
[21] Kun Wook Chung,et al. Imatinib Mesylate Reduces Endoplasmic Reticulum Stress and Induces Remission of Diabetes in db/db Mice , 2009, Diabetes.
[22] Y. Miki,et al. TTK/Mps1 controls nuclear targeting of c-Abl by 14-3-3-coupled phosphorylation in response to oxidative stress , 2008, Oncogene.
[23] G. Szot,et al. Tyrosine kinase inhibitors reverse type 1 diabetes in nonobese diabetic mice , 2008, Proceedings of the National Academy of Sciences.
[24] D. Mochly‐Rosen,et al. The PKCδ -Abl complex communicates ER stress to the mitochondria – an essential step in subsequent apoptosis , 2008, Journal of Cell Science.
[25] S. Y. Cajal,et al. c‐Abl activates p38 MAPK independently of its tyrosine kinase activity: Implications in cisplatin‐based therapy , 2008, International journal of cancer.
[26] D. Scheuner,et al. The unfolded protein response: a pathway that links insulin demand with beta-cell failure and diabetes. , 2008, Endocrine reviews.
[27] F. M. Thomas,et al. Selective tyrosine kinase inhibition by imatinib mesylate for the treatment of autoimmune arthritis. , 2006, The Journal of clinical investigation.
[28] Kathryn L. Lipson,et al. Regulation of insulin biosynthesis in pancreatic beta cells by an endoplasmic reticulum-resident protein kinase IRE1. , 2006, Cell metabolism.
[29] Tohru Natsume,et al. JNK phosphorylation of 14-3-3 proteins regulates nuclear targeting of c-Abl in the apoptotic response to DNA damage , 2005, Nature Cell Biology.
[30] E. Chevet,et al. Protein-tyrosine Phosphatase 1B Potentiates IRE1 Signaling during Endoplasmic Reticulum Stress* , 2004, Journal of Biological Chemistry.
[31] L. Glimcher,et al. Endoplasmic Reticulum Stress Links Obesity, Insulin Action, and Type 2 Diabetes , 2004, Science.
[32] Alex Matter,et al. Glivec (STI571, imatinib), a rationally developed, targeted anticancer drug , 2002, Nature Reviews Drug Discovery.
[33] Kiyoshi Inoue,et al. ASK1 is essential for endoplasmic reticulum stress-induced neuronal cell death triggered by expanded polyglutamine repeats. , 2002, Genes & development.
[34] K. Mori,et al. XBP1 mRNA Is Induced by ATF6 and Spliced by IRE1 in Response to ER Stress to Produce a Highly Active Transcription Factor , 2001, Cell.
[35] N. Narula,et al. Targeting of the c-Abl Tyrosine Kinase to Mitochondria in Endoplasmic Reticulum Stress-Induced Apoptosis , 2001, Molecular and Cellular Biology.
[36] D. Ron,et al. Diabetes mellitus and exocrine pancreatic dysfunction in perk-/- mice reveals a role for translational control in secretory cell survival. , 2001, Molecular cell.
[37] Jean Y. J. Wang. Regulation of cell death by the Abl tyrosine kinase , 2000, Oncogene.
[38] S. Goff,et al. c-Abl-induced apoptosis, but not cell cycle arrest, requires mitogen-activated protein kinase kinase 6 activation. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[39] Masahiko Kuroda,et al. Cloning of mammalian Ire1 reveals diversity in the ER stress responses , 1998, The EMBO journal.
[40] K. Roemer,et al. c-Abl tyrosine kinase can mediate tumor cell apoptosis independently of the Rb and p53 tumor suppressors , 1998, Oncogene.
[41] G. Bottazzo. Death of a Beta Cell: Homicide or Suicide? , 1986, Diabetic medicine : a journal of the British Diabetic Association.
[42] D. Accili,et al. How Does Type 1 Diabetes Develop? The Notion of Homicide or b -Cell Suicide Revisited , 2011 .
[43] Robert Hägerkvist,et al. Amelioration of diabetes by imatinib mesylate (Gleevec): role of beta-cell NF-kappaB activation and anti-apoptotic preconditioning. , 2007, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[44] Mark S. Anderson,et al. The NOD mouse: a model of immune dysregulation. , 2005, Annual review of immunology.